Cameroon Pharmaceuticals and Healthcare Report Q2 2016
BMI View: Economic expansion in Cameroon, driven mainly by ambitious investment projects in theinfrastructure network, will have a positive effect on overall economic activity and private consumptionover the next few years, which will benefit pharmaceutical and healthcare sector growth. In line with ourview in the prior quarter, such economic trends will continue to be reflected in a modest, but rising interestby investors in pharmaceutical and healthcare sector opportunities in the country, which is illustrated byrecent industrial and commercial investments by Tunisian pharmaceutical firm Teriak Laboratories inDouala, Cameroon. However, despite gradual efforts by Cameroonian authorities to improve the overallbusiness environment, this will remain significantly challenging, while political risks are weighed to thedownside due to succession uncertainty and regional instability, weighing on the country's full potential.
Headline Expenditure Projections
Pharmaceuticals: XAF217.14bn (USD364mn) in 2015 to XAF244.62bn (USD399mn) in 2016; +12.7%in local currency terms and +9.6% in US dollar terms. Forecast revised upwards from last quarter.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook